Clinical Research Directory
Browse clinical research sites, groups, and studies.
PRP for Treatment of Peyronie's Disease
Sponsor: University of Miami
Summary
The purpose of this study is to learn about the effects of Platelet-Rich Plasma (PRP) injection in men with Peyronie's Disease (PyD).
Official title: A Randomized, Double-Blind, Placebo Controlled, Crossover Trial on Safety and Efficacy of Autologous Platelet-Rich Plasma for Treatment of Peyronie's Disease
Key Details
Gender
MALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
65
Start Date
2021-03-29
Completion Date
2025-08-11
Last Updated
2026-08-03
Healthy Volunteers
No
Conditions
Interventions
Autologous Platelet-Rich Plasma (PRP)
Autologous platelet-rich plasma (PRP) prepared from the participant's own blood. Participants will receive 2 treatment sessions administered 15 ± 7 days apart, with 0.5 mL of PRP injected into the Peyronie's disease penile plaque at each session.
Placebo (Normal Saline)
Normal saline administered as a placebo comparator. Participants will receive 2 treatment sessions administered 15 ± 7 days apart, with 0.5 mL of normal saline injected into the Peyronie's disease penile plaque at each session.
Locations (1)
University of Miami
Miami, Florida, United States